Front Page
News & Info
Sinclair Range
About the Club
Easter Open
Competitions
Ambitions?
Members only
IoMRA
IoMTSF
Library
RO Rota
Contact us
Links
Weather:
  Local Forecast
  Next 5 Days
CSF(ED)2005
CSF(ED)2004
 
Get Adobe Reader
IOMSC: Drug Abuse
 50 metre ISSF rifle shooting in the Isle of Man Print version  
    

ISLE OF MAN RIFLE ASSOCIATION

ABUSE OF DRUGS


STATEMENT OF POLICY

General

  1. Drug abuse is the use by, or distribution to, shooters or other competitors of substances defined as being in contravention of rules currently in force.

  2. Any shooter or other competitor taking part in sport or related activities in the Isle of Man which fall within the jurisdiction of the Isle of Man Rifle Association must, if requested by an official designated for the purpose of drug control by the Association or the Manx drug control authorities, submit to a drug control test. Failure to do so will be treated as if a positive result had been obtained and dealt with accordingly.

  3. The identification of a forbidden substance and/or one of its metabolites, or the presence of specified amounts of endogenous substances subject to quantitative analysis, in a body fluid will constitute an offence and the offender may be subjected to disciplinary action.

  4. Any person assisting or inciting others in the contravention of drug abuse rules currently in force shall be considered as having committed an offence and may be subjected to disciplinary action.

Exceptions

  1. Except where expressly forbidden in other rules (eg competitions run under International Shooting Sport Federation (ISSF) rules), shooters and other competitors who have valid medical reasons for taking drugs which are proscribed will, subject to certain conditions, be permitted to enter and be eligible for selection for individual and team competitions falling within the jurisdiction of the Association. No inhibition will be placed upon their ability to compete and win prizes.

  2. Notwithstanding the foregoing, the right is reserved of the Association and the Manx drug control authorities to request a Medical Adviser, appointed for the purpose, to verify the details of any individual case with the competitor's doctor and failure on the part of the competitor to comply with such action, or the identification through such action of a false claim by the competitor, will constitute an offence and be dealt with accordingly.

Warning!!

It could be highly dangerous for a competitor to give up or reduce the dosage of a drug regularly taken. No competitor should take this course without medical advice.

October 1993